Pilot Study of Atorvastatin for Orthopedic Surgery Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

January 31, 2017

Conditions
Hip FractureMyocardial IschemiaInflammation
Interventions
DRUG

Atorvastatin

Atorvastatin or placebo will be started at least 4 hours prior to surgery, and continued nightly until postoperative day 45

DRUG

Placebo

Trial Locations (2)

10021

Hospital for Special Surgery, New York

10065

New York Presbyterian Hospital (Cornell), New York

All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Utah

OTHER

lead

Hospital for Special Surgery, New York

OTHER

NCT02197065 - Pilot Study of Atorvastatin for Orthopedic Surgery Patients | Biotech Hunter | Biotech Hunter